Proton Beam Therapy for Locally Recurrent Hepatocellular Carcinoma After Radiofrequency Ablation or Transcatheter Arterial Chemoembolization
Shingo Hashimoto(Aichi Cancer Center), Jun‐etsu Mizoe(Nagoya Medical Center), Makoto Nakanishi(The Cancer Institute Hospital), Shigeru Sasaki(Teikyo University), Yuta Shibamoto(Kyoto University Hospital), Hiromitsu Iwata, K. Nakajima(Nagoya Medical Center), Yuki Kuwabara(Nagoya Medical Center), Hiroyuki Ogino(Nagoya Medical Center), Kyoji Senoo(Nagoya Medical Center), Yukiko Hattori(Nagoya City University), F. Baba(Nagoya Medical Center)
International Journal of Radiation Oncology*Biology*Physics
September 23, 2017
Cited by 2
Related Papers
Navigating the DNA methylation landscape of cancer
|Trends in Genetics|2021|1k
Aberrant cell cycle checkpoint function and early embryonic death in <i>Chk1</i><sup>−/−</sup> mice
|Genes & Development|2000|469
Chk2‐deficient mice exhibit radioresistance and defective p53‐mediated transcription
|The EMBO Journal|2002|436